within Pharmacolibrary.Drugs.A_AlimentaryTractAndMetabolism.A10A_InsulinsAndAnalogues.A10AB01_InsulinHuman;

model InsulinHuman
  extends Pharmacolibrary.Drugs.ATC.A.A10AB01;

  annotation (Documentation(
info       = "<html><body><table><tr><td>name:</td><td>InsulinHuman</td></tr><tr><td>ATC code:</td><td>A10AB01</td></tr><td>route:</td><td>subcutaneous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Insulin (human) is a peptide hormone used primarily in the treatment of diabetes mellitus. It replaces or supplements endogenous insulin, facilitating the uptake of glucose by tissues. Human insulin is the standard therapeutic agent for controlling blood glucose in both type 1 and type 2 diabetes, and remains approved for clinical use globally.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters are reported for healthy adult subjects after subcutaneous administration.</p><h4>References</h4><ol><li><p>Setji, TL, et al., &amp; Feinglos, MN (2016). Technosphere insulin: inhaled prandial insulin. <i>Expert opinion on biological therapy</i> 16(1) 111â€“117. DOI:<a href=\"https://doi.org/10.1517/14712598.2016.1121230\">10.1517/14712598.2016.1121230</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/26567896/\">https://pubmed.ncbi.nlm.nih.gov/26567896</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial generated model</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end InsulinHuman;
